Vemurafenib Not Yet Recruiting Phase 2 Trials for Melanoma / Melanoma (Skin) / Melanoma Stage Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03224208Vemurafenib Plus Cobimetinib in Advanced or Metastatic Melanoma Patients